CBOE Forensic analysis
Price Targets (12m)
Detailed research
PART 1: TRADING EXECUTION
Trading Setup & Entry Strategy
CBOE is exhibiting strong bullish momentum, characterized by a 20-day gain of 21.29% and trading well above its 50-day SMA ($307.83) and 200-day SMA ($268.26). The RSI (14-day) at 70.51 indicates an overbought state, suggesting a potential short-term consolidation or minor pullback before further upside.
- >Entry Zone: Scale in with 30% of the position at $355.00 (approaching 10-day SMA support). Add 40% if the price tests the $340.00 - $345.00 level.
- >Stop Loss: $305.00 (Hard stop). Placed just below the 50-day SMA to protect against a broader market correction.
- >Take Profit: Initial target $385.00 (Bollinger Upper Band), secondary target $400.00 (Psychological resistance).
- >Position Size: 3-4% of total portfolio.
- >Risk/Reward: Target 1:2.5 R/R.
Executive Summary
CBOE is firing on all cylinders, buoyed by strong derivatives volume growth (index options ADV +29%) and successful strategic realignments to shed underperforming units. While currently overbought, the underlying fundamental trend remains positive. Analysis Date: 2026-05-20.
PART 2: DETAILED RESEARCH
Recent Material Events (8-K Analysis)
- >Strategic Realignment (May 1, 2026): Announced a major workforce reduction (approx. 20% total) and structural optimization. Expected pre-tax charges of $36M - $46M with annual cost savings of $40M - $50M. This signals management's aggressive focus on margin expansion.
- >Divestitures: Definitive agreement reached on April 22, 2026, to sell Cboe Australia and Cboe Canada to TMX Group for $300M, sharpening focus on high-margin derivatives.
Business Model Analysis
- >Revenue Mix: Heavily weighted toward Derivatives Markets ($609.3M), which remains the primary growth engine. Data Vantage continues to show high margin accretion ($181.3M revenue).
- >Financial Health: Robust balance sheet with $2.13B in cash. Total Debt $1.44B is manageable given the high free cash flow generation and clear deleveraging path post-divestiture.
Technical Analysis & Trade Timing
- >Status: Bullish Uptrend. The stock is in a confirmed breakout phase.
- >Reconciliation: The RSI at 70.51 is a warning sign of an overextended rally. While the fundamentals support a BUY, the technical overbought status dictates a wait-for-pullback strategy rather than chasing current levels.
Investment Recommendation
Recommendation: BUY on pullbacks. Conviction Score: 8/10. CBOE is a high-quality compounder with a clear strategy to improve margins through layoffs and asset sales.
One-Liner Thesis: CBOE’s aggressive focus on operational efficiency and dominant position in high-growth index options make it a premium play, provided traders respect the current overbought technicals by buying the dip.